Bajaj Finserv
|

Bajaj Finance Limited

|
Sign In
EMI Card
Notifications
Notifications
Cart
Prime
Partners
  • Fixed Deposit (IFA) Partner Fixed Deposit (IFA) Partner
  • Loan (DSA) Partner Loan (DSA) Partner
  • Debt Management Partner Debt Management Partner
  • EMI Network Partner EMI Network Partner
  • Become a Merchant Become a Merchant
  • Demat and mutual fund partner Demat and mutual fund partner
  • Partners Sign In Partners Sign In
Menu
  • Loans
    • All Loans
    • Personal Loan Apply Online Check Offer
      • Overview Flexi Personal Loan Features and Benefits Eligibility Calculator Fees and Charges How to Apply FAQs Manage your Loans Manage your Flexi Loans Contact Us
      • Loans for your Goals

        • Loan for Wedding
        • Loan for Higher Education
        • Loan for Home Renovation
        • Loan for Medical Emergency
    • Insta Personal Loan Check Offer Pre-approved Offer
      • Overview Features Eligibility Calculator Fees and Charges How to Apply Manage your Loans
      • Loans for your Goals

        • Loan for Wedding
        • Loan for Higher Education
        • Loan for Home Renovation
        • Loan for Medical Expenses
    • Business Loan Apply Online Check Offer

        Unsecured

      • MSME World Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • Secured

      • Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • Types of Business Loans

      • Business Loan for Chartered Accountants Loan Against Property for Chartered Accountant Personal Loan for Chartered Accountants
    • Gold Loan Apply Online

        New Loan

      • Overview Features EMI Calculator Eligibility How to Apply Manage your Gold Loan Interest Rate and Charges Gold Rate
      • Balance Transfer

      • Overview Features EMI Calculator Eligibility How to Apply Interest Rate and Charges
    • Loans for Doctors Apply Online Check Offer

        UNSECURED

      • Doctor World Overview Features Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • SECURED

      • Overview EMI Calculator Features Eligibility How to Apply Fees and charges Manage your loan
      • Types of Doctor Loans

      • Business Loan for Doctors Personal Loan For Doctors Loan Against Property for Doctors Indemnity Insurance Medical Practice Loan
    • Medical Equipment Finance Apply Online
      • Overview Features Eligibility How to Apply Fees & Charges
    • Loans for CAs Apply Online Check Offer

        UNSECURED

      • Overview Features Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • SECURED

      • Overview EMI Calculator Features Eligibility How to Apply Fees and charges Manage your loan
      • Types of CA Loans

      • Business Loan for Chartered Accountants Loan Against Property for Chartered Accountants Personal Loan for Chartered Accountants
    • Commercial Lending
      • Overview Term Loans Working Capital Products Corporate Lease Rental Discounting
    • Home Loan Apply Online Check Offer

        Home Loan

      • Home Loan World Overview Features EMI Calculator Eligibility How to Apply Fees and Charges Home Loan Interest Rate
      • Balance Transfer

      • Overview Features Eligibility How to Apply Fees and Charges
      • Categories

      • Home Loan for Doctors Home Loan for Self-employed Home Loan for Salaried
      • Categories

      • Home Loan Balance Transfer for Doctors Home Loan Balance Transfer for Self-employed Home Loan Balance Transfer for Salaried
    • Loan Against Property Apply Online

        LOAN AGAINST PROPERTY

      • Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Loan Against Property Interest Rate
      • BALANCE TRANSFER

      • Overview Features Eligibility How to Apply Fees & Charges
    • Lease Rental Discounting
    • Loan Against Securities Apply Online

        LOAN AGAINST SHARES

      • Overview Features Eligibility How to Apply Fees & Charges Manage your Loan Against Securities FAQ
      • Loan Against Mutual Funds

      • Overview Features Eligibility How to Apply Fees & Charges FAQ
      • Loan Against Bonds

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
      • Loan Against Insurance Policy

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
      • ESOP Financing

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
    • Two-wheeler Loan Apply Online Check Offer
      • Overview Eligibility Features Interest Rates How to Apply Manage your Two-wheeler Loan FAQs
    • New Car Finance Apply Now Check Offer
      • Auto World Overview Features Eligibility How to Apply Interest Rates and Charges FAQs Manage your loan Manage your flexi loan
    • Used Car Loan Apply Now Check Offer

        Used Car Finance

      • Auto World Explore Used Cars and Loan Overview Features and benefits Eligibility EMI Calculator Used Car Loan Eligibility Calculator Fees and charges How to Apply FAQs Manage your loan Manage your flexi loan
      • Categories

      • Loan against car Car loan balance transfer
    • Loan Against Car Apply Now Check Offer

        Loan Against Car

      • Auto World Overview Features and benefits Eligibility EMI Calculator Loan Against Car Eligibility Calculator Fees and charges How to Apply FAQS Manage your loan Manage your flexi loan
      • Categories

      • Used car loan Car loan balance transfer
    • Car Loan Balance Transfer and Top-up Apply Now Check Offer

        Balance Transfer

      • Auto World Overview Features and benefits Eligibility EMI Calculator Car Loan Balance Transfer and Top Up Eligibility Calculator Fees and Charges How to Apply Manage your loan FAQS Manage your flexi loan
      • Categories

      • Used car loan Loan against car
    • Microfinance Group Loan
    • Tractor Loan
    • Loan for Lawyer
    • Easy EMI Loan
  • All on EMI
    • Electronics
    • Two-wheelers
    • Lifestyle
    • Travel
      • Our Partner Make My Trip Goibibo IRCTC
    • Shop on Ecommerce
      • Our Partner Flipkart Amazon
    • Offers & Promotions
    • Tractor
  • Bajaj Mall
    • Smartphones
    • Washing Machines
    • LED TVs
    • Refrigerators
    • Air Conditioners
    • Water Purifiers
    • Two-wheelers
    • Smartwatches
    • Laptops
    • Mattresses
    • Furniture
    • Kitchen Appliances
    • Cycles
    • Fitness Equipment
    • Air Cooler
    • Watches
    • Audio Devices
    • Camera Accessories
  • Card
    • Insta EMI Card Apply Online
      • Overview Features and Benefits Eligibility Fees and Charges How to Apply Manage your Insta EMI Card Contact Us
  • Investments
    • All Investments
    • Fixed Deposit Open FD
      • Overview FD Calculator Features and Benefits FD Interest Rates Eligibility and Documents How to Invest FAQs Manage your FD Contact Us
      • FIXED DEPOSIT FOR YOUR GOALS

        • Fixed Deposit for Retirement Fund
        • Fixed Deposit for Higher Education
        • Fixed Deposit for Home Expenses
        • Fixed Deposit for Wedding Expenses
    • Mutual Funds Open MF Account Explore Funds

        About the Product

      • SIP Calculator Overview Explore All MFs How to Invest FAQs Contact Us
      • Fund Category

      • Debt Funds Equity Funds Hybrid Funds ELSS Funds Thematic Funds Multi Cap Fund NFO Large Cap Mutual Funds Mid Cap Mutual Funds Small Cap Mutual Funds Liquid Mutual Funds Aggressive Hybrid Mutual Funds
      • Funds by Returns

      • 1 Month Returns 3 Months Returns 1 Year Returns 3 Years Returns Max Returns
      • Quick Links

      • Portfolio Order in progress Open mutual fund account Dashboard New Fund Offer (NFO)
    • Stock Trading Open A/C
      • Start Trading Open Demat Account Overview FAQ Contact Us
    • Partner Portal
    • Become Our Partner
  • Insurance
    • Insurance Mall
    • Health Insurance Explore Plans

        Health Insurance

      • Overview Get Quote FAQs
      • Family Health Insurance

      • Aditya Birla Group Activ Health Plan (ABCD) Bajaj Allianz Health Guard Insurance Plan ManipalCigna Pro-Health Group Niva Bupa Health Plus Plan Aditya Birla Active Assure Diamond
      • Top-up Health Insurance

      • Group Activ Health Super Top-Up Bajaj Allianz Extra care plus plan
      • Partners

      • Aditya Birla Health Insurance Bajaj Allianz General Insurance Niva Bupa Health Insurance Bajaj Finserv Health ManipalCigna Health Insurance
    • Car Insurance Explore Plans

        Car Insurance

      • Overview Get Quote FAQs
      • Partners

      • ACKO General Insurance Bajaj Allianz General Insurance SBI General Insurance
      • Comprehensive Car Insurance

      • ACKO Car Insurance Bajaj Allianz Car Insurance SBI General Car Insurance
      • Own Damage

      • Bajaj Allianz Car Insurance SBI General Car Insurance
    • Pocket Insurance Explore Plans

        Best Seller

      • Personal Accident Cover Group Activ Health Super top up Cover
      • Under 699

      • Cancer Secure Gym Injury Insurance Pregnancy Complications Cover Baggage Insurance
      • Health Must Have

      • Niva Bupa Health Plus Dental Cover Sports/Fitness Injury Fracture Cover Health Plus Hospital Cash
      • Monsoon Insurance

      • Dengue & Malaria Cover Monsoon Insurance Viral Fever(Infection) CPP Liv Protect Group Activ Secure Policy- Personal Accident Cover 18-55 Years
    • Investment Plans Explore Plans

        Investment Plans

      • Overview
      • Partners

      • HDFC Life Bajaj Allianz Life Insurance
      • Guaranteed Savings

      • HDFC Life Guaranteed Savings Plan Bajaj Allianz Life POS Goal Suraksha Plan
    • Life Insurance Explore Plans

        Life Insurance

      • Overview Get Quote
      • Partner

      • Bajaj Allianz Life Insurance HDFC Life insurance Future Generali India Life Insurance
    • Professional Indemnity Explore Now

        Professional Indemnity

      • Overview Get Quote Bajaj Allianz Professional Indemnity Insurance Plan View All
      • Partners

      • Bajaj Allianz General Insurance
    • Manage your Insurance
  • Payments
    • All Payments
    • Mobile Recharge Pay Now
      • Jio Airtel Vi BSNL
    • Electricity Bill Payment Pay Now
      • Maharashtra State Electricity Distbn Co Ltd West Bengal Electricity Torrent Power Tamil Nadu Electricity Board (TNEB) Central Power Distribution Corporation Ltd. of Andhra Pradesh (APCPDCL) Calcutta Electric Supply Corporation (CESC) Jaipur Vidyut Vitran Nigam (JVVNL) APEPDCL-Eastern Power Distribution CO AP Ltd South Bihar Power Distribution Company Ltd. Southern Power Distribution Co Ltd of Andhra Pradesh Purvanchal Vidyut Vitaran Nigam Limited
    • Gas Booking Pay Now
      • Indane Gas (Indian Oil) Bharat Gas (BPCL) HP Gas (HPCL)
    • Loan Repayment Pay Now
      • Bajaj Finance Limited Agent Collection DMI Finance Private Limited Annapurna Finance Private Limited-MFI Bajaj Auto Finance Ujjivan Small Finance Bank TVS Credit IIFL Finance Limited
    • FASTag Buy New Recharge
      • IDFC FIRST Bank - FASTag Airtel Payments Bank NETC FASTag ICICI Bank FASTag HDFC  Bank - FASTag State Bank of India - NETC FASTag Kotak Mahindra Bank - FASTag Axis Bank FASTag IndusInd Bank FASTag
    • DTH Pay Now
      • Dish TV Videocon D2H Airtel DTH Tata Sky Sun Direct TV
    • Credit Card Bill payment Pay Now
      • SBI Card RBL Bank Credit Card HDFC Bank Credit Card ICICI Bank Credit Card Axis Bank Credit Card DBS Credit Card BoB Credit Card IDFC FIRST Bank Credit Card Yes Bank Credit Card Kotak Mahindra Bank Credit Card AU Bank Credit Card
    • Bajaj Pay Wallet
    • Bajaj Pay Gift Card Buy Now
      • My Cards Gift Card Categories
    • Rewards
      • Rewards & Offers Flipkart Gift Card Redbus Gift Card Swiggy Gift Card Amazon Gift Card Zomato Gift Card
  • Offers
    • All Offers
    • Loans
    • Electronics and Appliances
    • Personal Loan
    • EMI Card
    • Investment
    • Business Loan
    • Lifestyle
    • Home Loan
    • Insurance
    • Doctor Loan
    • Two wheeler
    • CA Loan
    • Used Cars
    • Loan Against Securities
    • Broking
    • Rewards
    • Gold Loan
    • Payments
  • Services
    • Locate Us
      • Branches EMI Network Partner Stores Hospitals & Wellness Centres Insurance Network Hospitals Collection Centres
    • All Service Guides
    • Raise a Request
      • Overview Raise a Request Follow-up on an open request Re-open a closed request
    • Manage your Profile
      • Overview Contact Details Personal Details GST Details
    • Manage your Mandate
      • Overview Register Mandate Change Mandate
    • Repay your Loans
      • Overview Clear Overdue EMIs Pay Advance EMIs Part-prepay your Loans Foreclose your Loans Manage your loan settlement
    • Manage your Loans
      • Overview Consumer Durable Loans Flexi Loans Loan Against Fixed Deposit Loan Against Securities Gold Loan Two-wheeler Loan
    • Manage your Cards
      • Insta EMI card Health EMI Network Card
    • Manage your Investments
      • Fixed Deposit Systematic Deposit Plan
    • Manage your Insurance
      • Overview Policy Details Renew your Policy Claim your Policy Cancel your Policy Surrender your Policy
  • About Bajaj Finserv
    • Investor Relations
    • People and Committees
    • About Us
    • Impact
    • TICC
    • Careers
  • pay emi image Pay EMI
  • Do not call image Do not call
  • Download the app image Download the app
Sign In

Main Menu

  • Food & Grocery
    Main Menu
    Food & Grocery
    • Food & Beverages
    • Grocery
    • Fashion
    • Beauty & Personal Care
    • Health & Wellness
    • Home & Kitchen
  • Bajaj Pay
    Main Menu
    Bajaj Pay
    • Bajaj Pay
    • Wallet
    • Refer & Earn
    • Mobile Recharge
    • Buy FASTag
    • Bill Payments & Other Recharges
    • Add Money
  • Loans
    Main Menu
    Loans
    • Personal Loan
    • Gold Loan
    • Business Loan
    • Loan for Doctors
    • Home Loan
    • Secured Business Loan
    • Loan Against Property
    • Loan Against Shares
    • Loan for Chartered Accountants
    • Medical Equipment Finance
    • Loan Against Property Balance Transfer
    • Home Loan Balance Transfer
    • Loan Against Mutual Funds
    • Loan Against Bonds
    • Loan Against Insurance Policy
    • ESOP Financing
    • Two-wheeler Loan
    • Buy a Used Car
    • Tractor Loan
    • Used Car Loan
    • Loan Against Car
    • Car Loan Balance Transfer and Top-up
    • New Car Loan
    • Loan for Lawyer
    • Industrial Equipment Finance
    • Industrial Equipment Balance Transfer
    • Industrial Equipment Refinance
    • Easy EMI Loan
  • Electronics & Smartphones
    Main Menu
    Electronics & Smartphones
    • Smartphones
    • Air Conditioner
    • Led TVs
    • Air Coolers
    • Refrigerators
    • Washing Machines
    • Laptops
    • Easy EMI Loan
  • EMI Card
    Main Menu
    EMI Card
    • Insta EMI Card
  • Share Market
    Main Menu
    Share Market
    • Trading Account
    • Open Demat Account
    • Margin Trading Financing
    • Share Market
    • Invest in IPO
    • All stocks
    • Top gainers
    • Top losers
    • 52 week high
    • 52 week low
    • Loan against shares
  • MSME World
    Main Menu
    MSME World
    • Business Loan
    • Secured Business Loan
    • Loan against property
    • Loans against property balance transfer
    • Loan against shares
    • Home Loan
    • Loans against mutual funds
    • Loan against bonds
    • Loan against insurance policy
    • Industrial Equipment Finance
    • Industrial Equipment Balance Transfer
    • Industrial Equipment Refinance
  • Insurance
    Main Menu
    Insurance
    • Health Insurance
    • Term Life Insurance
    • ULIP Plan
    • Savings Plan
    • Retirement Plans
    • Child Plans
    • Investment Plans
    • Wallet Care
    • Waller Care Entertainment +
    • Personal Accident Care
    • EMI/SIP Cover
    • Health Prime Max
    • Fonesafe Lite
    • Mobile Protect
    • Wallet Protekt
    • Dengue Cover
    • Niva Bupa Health Plus
    • Health Plus Hospital Cash
    • Four Wheeler Insurance
  • Bajaj Prime
    Main Menu
    Bajaj Prime
    • Get Bajaj Prime
  • Investments
    Main Menu
    Investments
    • Fixed Deposit
    • Renew Fixed Deposit
    • ULIP Plan
    • Savings Plan
    • Retirement Plans
    • Child Plans
    • Free Demat Account
    • Invest in Stocks
    • Invest in IPO
    • Margin Trading Facility
    • Equity Mutual Funds
    • Debt Mutual Funds
    • Hybrid Mutual Funds
    • New Fund Offers
    • Open Mutual Fund Account
  • Gold Loan
    Main Menu
    Gold Loan
    • Apply for Gold Loan
    • Transfer your Gold Loan with Us
  • Two Wheeler World
    Main Menu
    Two Wheeler World
    • Bike
    • Scooter
    • Electric Vehicle
    • Best Sellers
    • Popular Brands
  • Credit Score
    Main Menu
    Credit Score
    • Check your Credit Score
  • Fun Zone
    Main Menu
    Fun Zone
    • Engagement Zone
    • Game Zone
  • Auto World
    Main Menu
    Auto World
    • New Car Loan
    • Used Car Loan
    • Loan Against Car
    • Car Loan Balance Transfer and Top-up
    • Buy a Used Car
  • Easy EMI Loan
    Main Menu
    Easy EMI Loan
    • Mobiles and Electronics on Easy EMI
  • Calculators
    Main Menu
    Calculators
    • Personal Loan EMI Calculator
    • Personal Loan Eligibility Calculator
    • Home Loan EMI Calculator
    • Home Loan Eligibility Calculator
    • Good & Service Tax (GST) Calculator
    • Flexi Day Wise Interest Calculator
    • Flexi Transaction Calculator
    • Secured Business Loan Eligibility Calculator
    • Fixed Deposits Interest Calculator
    • Two wheeler Loan EMI Calculator
    • New Car Loan EMI Calculator
    • Used Car Loan EMI Calculator
    • All Calculator
  • Lifestyle
    Main Menu
    Lifestyle
    • Hot Deals
    • Clearance Sale
    • Kitchen Appliances
    • Tyres
    • Camera & Accessories
    • Mattresses
    • Furniture
    • Watches
    • Music & Audio
    • Cycles
    • Mixer & Grinder
    • Luggage & Travel
    • Fitness Equipment
    • Fans
  • Doctor World
    Main Menu
    Doctor World
    • Personal Loan for Doctors
    • Business loan for Doctors
    • Medical Equipment Finance
    • Secured Business Loan
    • Loan against property
    • Loan against share
    • Gold Loan
    • Home Loan
  • All on EMI
    Main Menu
    All on EMI
    • Smartphones
    • Air Conditioners
    • LED TVs
    • Air Coolers
    • Refrigerators
    • Washing Machines
    • Laptops
    • Water Purifiers
    • Tablets
    • Kitchen Appliances
    • Mattresses
    • Furniture
    • Music and Audio
    • Cameras & Accessories
    • Cycle
    • Watches
    • Tyres
    • Luggage & Travel
    • Fitness Equipment
    • Tractor
    • Easy EMI Loan
  • Home Loan World
    Main Menu
    Home Loan World
    • Home Loan
    • Transfer your existing Home loan
    • Loan against Property
    • Home Loan for Salaried
    • Home loan for self employed
    • Home Loan EMI Calculator
    • Home Loan eligibility calculator
    • Home Loan balance transfer
  • Deals and Savings
    Main Menu
    Deals and Savings
    • Easy EMI
    • Offer World
    • 1 EMI OFF
    • New Launches
    • Zero Down Payment
    • Clearance Sale
    • Bajaj Mall Sale
  • Articles
    Main Menu
    Articles
    • Articles
  • Loan Payments
    Main Menu
    Loan Payments
    • Overdue Payments
    • Other Payments
  • Bank details/ Documents
    Main Menu
    Bank details/ Documents
    • Document Center
    • Bank details & Documents
    • Tax Invoice Certificate
  • Do Not Call Service
    Main Menu
    Do Not Call Service
    • Do Not Call Service
  • Your Things
    Main Menu
    Your Things
    • Your Orders
    • Hamara Mall Orders
  • Rewards
    Main Menu
    Rewards
    • Explore Bajaj Prime
    • Explore Rewards
    • Buy Deals & Gift cards
  • Partners
    Main Menu
    Partners
    • Fixed Deposit (IFA) Partner
    • Loan (DSA) Partner
    • Debt Management Partner
    • EMI Network Partner
    • Become a Merchant
    • Partner Sign-in
  • What's New
    Main Menu
    What's New
    • Food & Shopping
    • Credit Card Hub
    • ULIP Plans
    • Top Gainers Stock
    • Top Losers Stock
    • Saving Plan
    • Term Insurance
    • Easy EMI Loan
  • Watch Live
    Main Menu
    Watch Live
    • Live Videos
  • Help and Support
  • Settings
    Main Menu
    Settings
    • Update Profile
    • Manage Consent
    • Refer and Earn
    • About Us
    • Important Information
    • Terms of Service
    • Privacy Policy
    • Fair Practice Code
    • Citizen Charter
    • LogOut
    • TICC
  • Home
  • Account
  • More
  • Pay EMIs
  • Menu
Menu
Food & Grocery

Food & Grocery

  • Food & BeveragesFood & Beverages
  • GroceryGrocery
  • FashionFashion
  • Beauty & Personal CareBeauty & Personal Care
  • Health & WellnessHealth & Wellness
  • Home & KitchenHome & Kitchen
Bajaj Pay

Bajaj Pay

  • Bajaj PayBajaj Pay
  • WalletWallet
  • Refer & EarnRefer & Earn
  • Mobile RechargeMobile Recharge
  • Buy FASTagBuy FASTag
  • Bill Payments & Other RechargesBill Payments & Other Recharges
  • Add MoneyAdd Money
Loans

Loans

  • Personal LoanPersonal Loan
  • Gold LoanGold Loan
  • Business LoanBusiness Loan
  • Loan for DoctorsLoan for Doctors
  • Home LoanHome Loan
  • Secured Business LoanSecured Business Loan
  • Loan Against PropertyLoan Against Property
  • Loan Against SharesLoan Against Shares
  • Loan for Chartered AccountantsLoan for Chartered Accountants
  • Medical Equipment FinanceMedical Equipment Finance
  • Loan Against Property Balance TransferLoan Against Property Balance Transfer
  • Home Loan Balance TransferHome Loan Balance Transfer
  • Loan Against Mutual FundsLoan Against Mutual Funds
  • Loan Against BondsLoan Against Bonds
  • Loan Against Insurance PolicyLoan Against Insurance Policy
  • ESOP FinancingESOP Financing
  • Two-wheeler LoanTwo-wheeler Loan
  • Buy a Used CarBuy a Used Car
  • Tractor LoanTractor Loan
  • Used Car LoanUsed Car Loan
  • Loan Against CarLoan Against Car
  • Car Loan Balance Transfer and Top-upCar Loan Balance Transfer and Top-up
  • New Car LoanNew Car Loan
  • Loan for LawyerLoan for Lawyer
  • Industrial Equipment FinanceIndustrial Equipment Finance
  • Industrial Equipment Balance TransferIndustrial Equipment Balance Transfer
  • Industrial Equipment RefinanceIndustrial Equipment Refinance
  • Easy EMI LoanEasy EMI Loan
Electronics & Smartphones

Electronics & Smartphones

  • SmartphonesSmartphones
  • Air ConditionerAir Conditioner
  • Led TVsLed TVs
  • Air CoolersAir Coolers
  • RefrigeratorsRefrigerators
  • Washing MachinesWashing Machines
  • LaptopsLaptops
  • Easy EMI LoanEasy EMI Loan
EMI Card

EMI Card

  • Insta EMI CardInsta EMI Card
Share Market

Share Market

  • Trading AccountTrading Account
  • Open Demat AccountOpen Demat Account
  • Margin Trading FinancingMargin Trading Financing
  • Share MarketShare Market
  • Invest in IPOInvest in IPO
  • All stocksAll stocks
  • Top gainersTop gainers
  • Top losersTop losers
  • 52 week high52 week high
  • 52 week low52 week low
  • Loan against sharesLoan against shares
msme-world

MSME World

  • Business LoanBusiness Loan
  • Secured Business LoanSecured Business Loan
  • Loan against propertyLoan against property
  • Loans against property balance transferLoans against property balance transfer
  • Loan against sharesLoan against shares
  • Home LoanHome Loan
  • Loans against mutual fundsLoans against mutual funds
  • Loan against bondsLoan against bonds
  • Loan against insurance policyLoan against insurance policy
  • Industrial Equipment FinanceIndustrial Equipment Finance
  • Industrial Equipment Balance TransferIndustrial Equipment Balance Transfer
  • Industrial Equipment RefinanceIndustrial Equipment Refinance
Insurance

Insurance

  • Health InsuranceHealth Insurance
  • Term Life InsuranceTerm Life Insurance
  • ULIP PlanULIP Plan
  • Savings PlanSavings Plan
  • Retirement PlansRetirement Plans
  • Child PlansChild Plans
  • Investment PlansInvestment Plans
  • Wallet CareWallet Care
  • Waller Care Entertainment +Waller Care Entertainment +
  • Personal Accident CarePersonal Accident Care
  • EMI/SIP CoverEMI/SIP Cover
  • Health Prime MaxHealth Prime Max
  • Fonesafe LiteFonesafe Lite
  • Mobile ProtectMobile Protect
  • Wallet ProtektWallet Protekt
  • Dengue CoverDengue Cover
  • Niva Bupa Health PlusNiva Bupa Health Plus
  • Health Plus Hospital CashHealth Plus Hospital Cash
  • Four Wheeler InsuranceFour Wheeler Insurance
Bajaj Prime

Bajaj Prime

  • Get Bajaj PrimeGet Bajaj Prime
Investments

Investments

  • Fixed DepositFixed Deposit
  • Renew Fixed DepositRenew Fixed Deposit
  • ULIP PlanULIP Plan
  • Savings PlanSavings Plan
  • Retirement PlansRetirement Plans
  • Child PlansChild Plans
  • Free Demat AccountFree Demat Account
  • Invest in StocksInvest in Stocks
  • Invest in IPOInvest in IPO
  • Margin Trading FacilityMargin Trading Facility
  • Equity Mutual FundsEquity Mutual Funds
  • Debt Mutual FundsDebt Mutual Funds
  • Hybrid Mutual FundsHybrid Mutual Funds
  • New Fund OffersNew Fund Offers
  • Open Mutual Fund AccountOpen Mutual Fund Account
Gold Loan

Gold Loan

  • Apply for Gold LoanApply for Gold Loan
  • Transfer your Gold Loan with UsTransfer your Gold Loan with Us
Two Wheeler World

Two Wheeler World

  • BikeBike
  • ScooterScooter
  • Electric VehicleElectric Vehicle
  • Best SellersBest Sellers
  • Popular BrandsPopular Brands
Credit Score

Credit Score

  • Check your Credit ScoreCheck your Credit Score
Fun Zone

Fun Zone

  • Engagement ZoneEngagement Zone
  • Game ZoneGame Zone
Auto World

Auto World

  • New Car LoanNew Car Loan
  • Used Car LoanUsed Car Loan
  • Loan Against CarLoan Against Car
  • Car Loan Balance Transfer and Top-upCar Loan Balance Transfer and Top-up
  • Buy a Used CarBuy a Used Car
Easy EMI Loan

Easy EMI Loan

  • Mobiles and Electronics on Easy EMIMobiles and Electronics on Easy EMI
Calculators

Calculators

  • Personal Loan EMI CalculatorPersonal Loan EMI Calculator
  • Personal Loan Eligibility CalculatorPersonal Loan Eligibility Calculator
  • Home Loan EMI CalculatorHome Loan EMI Calculator
  • Home Loan Eligibility CalculatorHome Loan Eligibility Calculator
  • Good & Service Tax (GST) CalculatorGood & Service Tax (GST) Calculator
  • Flexi Day Wise Interest CalculatorFlexi Day Wise Interest Calculator
  • Flexi Transaction CalculatorFlexi Transaction Calculator
  • Secured Business Loan Eligibility CalculatorSecured Business Loan Eligibility Calculator
  • Fixed Deposits Interest CalculatorFixed Deposits Interest Calculator
  • Two wheeler Loan EMI CalculatorTwo wheeler Loan EMI Calculator
  • New Car Loan EMI CalculatorNew Car Loan EMI Calculator
  • Used Car Loan EMI CalculatorUsed Car Loan EMI Calculator
  • All CalculatorAll Calculator
Lifestyle

Lifestyle

  • Hot DealsHot Deals
  • Clearance SaleClearance Sale
  • Kitchen AppliancesKitchen Appliances
  • TyresTyres
  • Camera & AccessoriesCamera & Accessories
  • MattressesMattresses
  • FurnitureFurniture
  • WatchesWatches
  • Music & AudioMusic & Audio
  • CyclesCycles
  • Mixer & GrinderMixer & Grinder
  • Luggage & TravelLuggage & Travel
  • Fitness EquipmentFitness Equipment
  • FansFans
Doctor World

Doctor World

  • Personal Loan for DoctorsPersonal Loan for Doctors
  • Business loan for DoctorsBusiness loan for Doctors
  • Medical Equipment FinanceMedical Equipment Finance
  • Secured Business LoanSecured Business Loan
  • Loan against propertyLoan against property
  • Loan against shareLoan against share
  • Gold LoanGold Loan
  • Home LoanHome Loan
All on EMI

All on EMI

  • SmartphonesSmartphones
  • Air ConditionersAir Conditioners
  • LED TVsLED TVs
  • Air CoolersAir Coolers
  • RefrigeratorsRefrigerators
  • Washing MachinesWashing Machines
  • LaptopsLaptops
  • Water PurifiersWater Purifiers
  • TabletsTablets
  • Kitchen AppliancesKitchen Appliances
  • MattressesMattresses
  • FurnitureFurniture
  • Music and AudioMusic and Audio
  • Cameras & AccessoriesCameras & Accessories
  • CycleCycle
  • WatchesWatches
  • TyresTyres
  • Luggage & TravelLuggage & Travel
  • Fitness EquipmentFitness Equipment
  • TractorTractor
  • Easy EMI LoanEasy EMI Loan
Home Loan World

Home Loan World

  • Home LoanHome Loan
  • Transfer your existing Home loanTransfer your existing Home loan
  • Loan against PropertyLoan against Property
  • Home Loan for SalariedHome Loan for Salaried
  • Home loan for self employedHome loan for self employed
  • Home Loan EMI CalculatorHome Loan EMI Calculator
  • Home Loan eligibility calculatorHome Loan eligibility calculator
  • Home Loan balance transferHome Loan balance transfer
Deals and Savings

Deals and Savings

  •  Easy EMI Easy EMI
  • Offer WorldOffer World
  • 1 EMI OFF1 EMI OFF
  • New LaunchesNew Launches
  • Zero Down PaymentZero Down Payment
  • Clearance SaleClearance Sale
  • Bajaj Mall SaleBajaj Mall Sale
Articles

Articles

  • ArticlesArticles
Loan Payments

Loan Payments

  • Overdue PaymentsOverdue Payments
  • Other PaymentsOther Payments
Bank details/ Documents

Bank details/ Documents

  • Document CenterDocument Center
  • Bank details & DocumentsBank details & Documents
  • Tax Invoice CertificateTax Invoice Certificate
Do Not Call Service

Do Not Call Service

  • Do Not Call ServiceDo Not Call Service
Your Things

Your Things

  • Your OrdersYour Orders
  • Hamara Mall OrdersHamara Mall Orders
Rewards

Rewards

  • Explore Bajaj PrimeExplore Bajaj Prime
  • Explore RewardsExplore Rewards
  • Buy Deals & Gift cardsBuy Deals & Gift cards
Partners

Partners

  • Fixed Deposit (IFA) PartnerFixed Deposit (IFA) Partner
  • Loan (DSA) PartnerLoan (DSA) Partner
  • Debt Management PartnerDebt Management Partner
  • EMI Network PartnerEMI Network Partner
  • Become a MerchantBecome a Merchant
  • Partner Sign-inPartner Sign-in
What's New

What's New

  •  Food & Shopping Food & Shopping
  • Credit Card HubCredit Card Hub
  • ULIP PlansULIP Plans
  • Top Gainers StockTop Gainers Stock
  • Top Losers StockTop Losers Stock
  • Saving PlanSaving Plan
  • Term InsuranceTerm Insurance
  • Easy EMI LoanEasy EMI Loan
Watch Live

Watch Live

  • Live VideosLive Videos
Help and Support
Settings
Update Profile Manage Consent Refer and Earn About Us Important Information Terms of Service Privacy Policy Fair Practice Code Citizen Charter LogOut TICC
Relations Documents Profile Loan Payments

Error

400

We are sorry.

There's nothing here yet.

BACK TO HOMEPAGE
  • Overview
  • Performance
  • Fundamentals
  • Financials
  • Technical summary
  • Shareholding pattern
  • About
  • View more stocks
  • All stocks
  • Top gainers
  • Top losers
  • FAQs

DR. REDDY S LABORATORIES

DRREDDY

NSE

BSE

Pharmaceuticals

₹ 1226.6

2.4 0.19%

OPEN DEMAT ACCOUNT

Stock price as on May 21 2025 01:03 PM

Stock performance

Performance

Company fundamentals

Fundamentals

Company financials

Financials

Stock technical summary

Technical summary

Company shareholding pattern

Shareholding pattern

About

About {Company_Name}

Similar stocks

Similar stocks

FAQs

FAQs

Performance Graph
YTD 1 Week 1 Months 3 Months 6 Months 1 Year 0.19% 1.41% 3.97% 4.54% 2.41% 5.9%

Dr. ReddyS Laboratories stock performance

Today’s low

1220.1

Today’s high

1256.6

1226.6

52 week low

1020.0

52 week high

1421.49

1233.0

Open

1225.1

Previous close

1224.2

Share volume

1509281.0

Total traded value (Lakh)

18609.43

Upper circuit

1346.6

Lower circuit

1101.8

Stock performance

This data indicates the stock's performance over a specific period, measured by tracking its price movements.

<p><b>Open</b></p> <p style="text-align: left;">The price at which a stock begins trading at the start of the trading day.<br /> </p> <p> </p> <p><b>Previous close</b></p> <p style="text-align: left;">The price at which a stock ended trading on the previous day.<br /> </p> <p> </p> <p><b>Share volume</b></p> <p style="text-align: left;">The total number of shares  traded during a specific period, typically within a trading day.</p> <p> </p> <p><b>Trade value</b></p> <p>The total value of all trades made during a specific period.<br /> </p> <p> </p> <p><b>Upper circuit</b></p> <p>The maximum allowed price increase in a stock during a single session, after which trading is temporarily paused.</p> <p> </p> <p><b>Lower circuit</b></p> <p>The maximum allowed price decrease in a stock during a single session, after which trading is temporarily paused.</p> <p> </p>

Dr. ReddyS Laboratories fundamentals

Market cap (Cr)
20461.93
P/E ratio (TTM)
19.11
Book value per share
₹ 0.0
Beta
0.54
Return on equity
19.42
Earnings per share (TTM)
₹ 64.11
Dividend yield
0.65%
Net profit/quarter (Cr)
₹ 1200.7

Fundamentals

Understand the common terms associated with a company's stock fundamentals

<p><b>Market cap</b></p> <p>The total value of a company's outstanding shares, calculated by multiplying the current stock price with the number of shares.<br> </p> <p>&nbsp;</p> <p><b>P/E ratio (TTM)</b></p> <p style="text-align: left;">The price-to-earnings ratio, showing how investors value a company by dividing the stock price by earnings per share (EPS).<br> </p> <p>&nbsp;</p> <p><b>Book value per share</b></p> <p style="text-align: left;">The value of a company per share, calculated by dividing the company's net assets by the total number of shares.</p> <p style="text-align: left;">&nbsp;</p> <p><b>Beta</b></p> <p>A measure of a stock’s volatility compared to the&nbsp; market:</p> <p>&nbsp;</p> <p>Beta of 1: Stock moves with the market.</p> <p>Beta &gt; 1: More volatile.</p> <p>Beta &lt; 1: Less volatile.</p> <p>&nbsp;</p> <p><b>Return on equity</b></p> <p style="text-align: left;">Indicates how profitable a company is compared to shareholder investment, calculated by dividing net income by shareholders' equity.<br> </p> <p>&nbsp;</p> <p><b>Earnings per share (TTM)</b></p> <p>The profit earned per share over the past 12 months.<br> </p> <p>&nbsp;</p> <p><b>Dividend yield</b></p> <p>The return on investment from dividends, calculated by dividing the annual dividend by the current share price.</p> <p>&nbsp;</p> <p><b>Net profit/quarter</b></p> <p>The profit a company makes in a quarter after all expenses and taxes are deducted.</p> <p>&nbsp;</p>

Dr. ReddyS Laboratories financials

(Values in Cr)

Revenue

Net income

Revenue

Particulars

202503 (₹ value in crores)

Revenue

5546.3

Operating expense

4415.5

Net income

1200.7

Net profit margin

21.64%

Earnings per share

14.41

EBITDA

1857.39

Effective tax rate

23.12
Revenue

Particulars

202412 (₹ value in crores)

Revenue

4997.8

Operating expense

4131.0

Net income

849.4

Net profit margin

16.99%

Earnings per share

10.2

EBITDA

1427.8

Effective tax rate

24.12
Revenue

Particulars

202409 (₹ value in crores)

Revenue

6678.8

Operating expense

4263.09

Net income

1882.1

Net profit margin

28.18%

Earnings per share

113.0

EBITDA

2929.2

Effective tax rate

28.72
Revenue

Particulars

202406 (₹ value in crores)

Revenue

5823.9

Operating expense

4145.1

Net income

1417.2

Net profit margin

24.33%

Earnings per share

85.1

EBITDA

2170.8

Effective tax rate

25.95
Revenue

Particulars

202403 (₹ value in crores)

Revenue

5081.8

Operating expense

3978.3

Net income

1034.8

Net profit margin

20.36%

Earnings per share

62.14

EBITDA

1591.3

Effective tax rate

22.72

(Values in Cr)

Revenue

Net income

Revenue Annual

Particulars

202503 (₹ value in crores)

Revenue

23046.8

Operating expense

16882.9

Net income

5349.4

Net profit margin

23.21%

Earnings per share

64.22

EBITDA

8385.19

Effective tax rate

26.07
Revenue Annual

Particulars

202403 (₹ value in crores)

Revenue

19404.1

Operating expense

14554.8

Net income

4342.0

Net profit margin

22.37%

Earnings per share

260.95

EBITDA

6788.7

Effective tax rate

25.02
Revenue Annual

Particulars

202303 (₹ value in crores)

Revenue

16899.1

Operating expense

13687.8

Net income

2612.8

Net profit margin

15.46%

Earnings per share

157.37

EBITDA

4806.1

Effective tax rate

32.41
Revenue Annual

Particulars

202203 (₹ value in crores)

Revenue

14315.3

Operating expense

12663.4

Net income

1623.2

Net profit margin

11.33%

Earnings per share

97.85

EBITDA

3076.1

Effective tax rate

27.0
Revenue Annual

Particulars

202103 (₹ value in crores)

Revenue

13281.4

Operating expense

11094.0

Net income

2186.4

Net profit margin

16.46%

Earnings per share

131.84

EBITDA

3937.89

Effective tax rate

28.46

Financials

<p><b>Quarterly</b>: Months listed along the bottom of the graph represent a quarter.</p> <p><b>Annual</b>: Months listed along the bottom of the graph represent a financial year.<br /> </p>

ROE

ROCE

Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1699.87

Return on Equity (ROE)

21.64

Return on Capital Employed (ROCE)

26.59

Total debt to equity ratio

0.06

EBITDA margin

31.57
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1405.34

Return on Equity (ROE)

21.21

Return on Capital Employed (ROCE)

25.99

Total debt to equity ratio

0.11

EBITDA margin

30.16
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1164.21

Return on Equity (ROE)

11.84

Return on Capital Employed (ROCE)

14.46

Total debt to equity ratio

0.17

EBITDA margin

20.06
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1072.02

Return on Equity (ROE)

11.74

Return on Capital Employed (ROCE)

15.29

Total debt to equity ratio

0.16

EBITDA margin

22.1
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

944.61

Return on Equity (ROE)

13.68

Return on Capital Employed (ROCE)

10.95

Total debt to equity ratio

0.2

EBITDA margin

17.97

ROE

ROCE

Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1459.23

Return on Equity (ROE)

19.42

Return on Capital Employed (ROCE)

25.4

Total debt to equity ratio

0.02

EBITDA margin

34.84
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1236.56

Return on Equity (ROE)

13.46

Return on Capital Employed (ROCE)

18.82

Total debt to equity ratio

0.06

EBITDA margin

28.33
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1111.56

Return on Equity (ROE)

9.19

Return on Capital Employed (ROCE)

11.63

Total debt to equity ratio

0.1

EBITDA margin

21.35
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

1032.48

Return on Equity (ROE)

11.5

Return on Capital Employed (ROCE)

15.04

Total debt to equity ratio

0.08

EBITDA margin

25.97
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

920.13

Return on Equity (ROE)

21.08

Return on Capital Employed (ROCE)

18.48

Total debt to equity ratio

0.09

EBITDA margin

30.49

Financials

<p>Months listed along the bottom of the graph represent a financial year.<br /> </p> <p>         </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of the single company.<br /> </p>

(Values in Cr)

Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

1727.7

38863.8

38863.8

Total Equity

28254.8

Shares Outstanding

166818266

Price to book ratio

4.22

Return on assets (%)

14.35

Return on capital (%)

18.65
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

1730.2

32285.1

32285.1

Total Equity

23286.1

Shares Outstanding

166527876

Price to book ratio

3.74

Return on assets (%)

13.96

Return on capital (%)

18.47
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

2419.2

29746.9

29746.9

Total Equity

19212.4

Shares Outstanding

166426049

Price to book ratio

3.87

Return on assets (%)

7.33

Return on capital (%)

9.79
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

2078.8

26616.8

26616.8

Total Equity

17641.7

Shares Outstanding

166301431

Price to book ratio

4.37

Return on assets (%)

7.33

Return on capital (%)

9.6
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

205.3

23225.3

23225.3

Total Equity

15598.8

Shares Outstanding

166172082

Price to book ratio

3.39

Return on assets (%)

8.72

Return on capital (%)

11.66

(Values in Cr)

Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

1216.9

30359.3

30359.3

Total Equity

24240.8

Shares Outstanding

166818466

Price to book ratio

4.22

Return on assets (%)

14.3

Return on capital (%)

17.4
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

645.8

25374.8

25374.8

Total Equity

20474.2

Shares Outstanding

166527876

Price to book ratio

3.74

Return on assets (%)

10.29

Return on capital (%)

12.76
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

2030.5

24495.6

24495.6

Total Equity

18336.2

Shares Outstanding

166426049

Price to book ratio

3.87

Return on assets (%)

6.62

Return on capital (%)

7.92
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

1646.5

21629.6

21629.6

Total Equity

16983.7

Shares Outstanding

166301431

Price to book ratio

4.37

Return on assets (%)

10.1

Return on capital (%)

12.04
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

39.2

19475.8

19475.8

Total Equity

15191.9

Shares Outstanding

166172082

Price to book ratio

3.39

Return on assets (%)

15.08

Return on capital (%)

18.07

Financials

<p>Months listed along the bottom of the graph represent a financial year.</p> <p> </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of a single company.<br /> </p>

(Values in Cr)

Net income

Net change

Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

7201.0

Cash from operations

6548.0

Cash from investing

-4028.3

Cash from financing

-376.3

Net change in cash

138.7

Free cash flow

8188.3
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

6048.5

Cash from operations

6958.9

Cash from investing

-4137.3

Cash from financing

-2686.1

Net change in cash

-935.9

Free cash flow

8091.2
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

3061.4

Cash from operations

3554.5

Cash from investing

-2638.7

Cash from financing

-242.2

Net change in cash

-70.1

Free cash flow

5020.5
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

2883.5

Cash from operations

4141.9

Cash from investing

-2266.0

Cash from financing

-29.8

Net change in cash

1274.5

Free cash flow

5116.0
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

1885.7

Cash from operations

3694.6

Cash from investing

-492.3

Cash from financing

-2515.9

Net change in cash

-24.1

Free cash flow

4179.2

(Values in Cr)

Net income

Net change

Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

5791.3

Cash from operations

4769.2

Cash from investing

-3430.3

Cash from financing

68.1

Net change in cash

87.5

Free cash flow

6130.29
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

3866.0

Cash from operations

5835.6

Cash from investing

-3447.6

Cash from financing

-2696.9

Net change in cash

-1091.6

Free cash flow

6835.8
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

2223.8

Cash from operations

1827.5

Cash from investing

-2038.0

Cash from financing

505.5

Net change in cash

-193.8

Free cash flow

3138.8
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

3056.2

Cash from operations

3962.2

Cash from investing

-1458.0

Cash from financing

-794.3

Net change in cash

1261.9

Free cash flow

4819.7
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

2775.8

Cash from operations

2316.1

Cash from investing

-1689.2

Cash from financing

-224.1

Net change in cash

-74.1

Free cash flow

2742.29

Financials

<p>Months listed along the bottom of the graph represent a financial year.</p> <p> </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of a single company.<br /> </p>

Company name

Price

P/E

P/B

Market cap

52 week low/high

38.57

20.74

2.1

295.57

34.11 / 77.7

121.65

15.21

1.22

1281.83

92.25 / 184.95

1454.5

22.28

3.76

117471.3

1310.05 / 1702.0

299.95

24.85

3.04

882.78

145.0 / 449.0

₹38.57

23.23

6.55

295.57

34.11 / 77.7

₹684.05

38.91

6.05

1977.63

548.05 / 861.4

₹7920.85

118.13

29.14

19802.13

5415.55 / 9199.0

₹121.65

18.57

1.21

1281.83

92.25 / 184.95

Dr. ReddyS Laboratories technical summary

1232.80.7
1
15
Bullish
1219.4
1207.8
1203.9
1192.3
1187.1
1182.6
1200.2
1220.5
1226.0
1199.8
1194.1
1190.3
1179.4
1162.5
1211.6
1262.3
1225.07
PIVOT
First support1215.73
Second support1207.27
Third support₹1197.93
RSI61.24
MACD16.81%
Commodity Channel Index (CCI)₹114.88
First resistance1233.53
Second resistance1242.87
Third resistance-1251.33
ADX28.67
Williams % R-15.66
Date2025-05-20
Same day804773
Week847997
Month1058182
1 year
5.9
3 years
12.93
Price change analysis
-1.41%
Over 1 month
-3.97%
Over 3 month
-4.54%
Over 6 month
-2.41%
Over 3 year
12.93%
Over 6 year
9.37%

Dr. ReddyS Laboratories shareholding pattern

Holding %

Public

10.44%

Promoter holdings

26.64%

FII

37.29%

DII

25.61%

Promoter shares

0%

Promoter shares

J P Morgan Chase Bank Na

G V Prasad

Satish Reddy Kallam

Life Insurance Corporation Of India P & Gs Fund

Icici Prudential Value Discovery Fund

Kallam Satish Reddy Huf

Nps Trust-a/c Sbi Pension Fund Scheme Tax Saver-tier 2

Nippon Life India Trustee Ltd-a/c-nippon India Nifty 50 Value 20 Index Fund

Gunupati Venkateswara Prasad Huf

First Sentier Investors Icvc - Stewart Investors Asia Pacific Leaders Sustainability Fund

Sbi Nifty Index Fund

Parag Parikh Flexi Cap Fund

Anuradha Gunupati

Sharathchandra Reddy Gunupati

Aps Trust

Vsd Holdings & Advisory Llp

K Vishal Reddy

K Shravya Reddy

Gunupati Mallika Reddy

G Vani Sanjana Reddy

Deepti Reddy Kallam

Share

Category

96312429
(11.54)%

Public Shareholding

96095920
(11.52)%

Shareholding of Promoter and Promoter Group

85738125
(10.27)%

Shareholding of Promoter and Promoter Group

60015393
(7.19)%

Public Shareholding

31659572
(3.79)%

Public Shareholding

27618385
(3.31)%

Shareholding of Promoter and Promoter Group

20423710
(2.45)%

Public Shareholding

16247593
(1.95)%

Public Shareholding

12717090
(1.52)%

Shareholding of Promoter and Promoter Group

12106171
(1.45)%

Public Shareholding

11411189
(1.37)%

Public Shareholding

10653386
(1.28)%

Public Shareholding

46025
(0.01)%

Shareholding of Promoter and Promoter Group

13000
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

0
(0)%

Shareholding of Promoter and Promoter Group

25695
(0)%

Shareholding of Promoter and Promoter Group

25700
(0)%

Shareholding of Promoter and Promoter Group

25700
(0)%

Shareholding of Promoter and Promoter Group

About Dr. ReddyS Laboratories

Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations. The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy's operates in markets across the globe. Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad. The company was established by Dr Anji Reddy with an initial capital outlay of Rs 25 lakh. It was founded to enable patients to access life-saving medicines and to use science and innovations to open new avenues to meet unmet medical needs. The company made their beginning with the manufacture of Active Pharmaceutical Ingredients and Intermediates (API) and commenced operations with a single drug in a 60-tonne facility near Hyderabad, India. In the year 1986, the company shares were listed on the Bombay Stock Exchange. Also, they entered international market with exports of Methyldopa. In the year 1987, the company obtained first USFDA approval for Ibuprofen API. In the year 1988, they acquired Benzex Laboratories Pvt Ltd to expand their Bulk Actives business. In the year 1990, they exported Norfloxacin and Ciprofloxacin to Europe and Far East. In the year 1991, they commenced formulation exports to Russia. In the year 1993, the company established Dr. Reddy's Research Foundation and initiated drug discovery programme. In the year 1994, they finished dosages facility established to cater to highly regulated markets such as the US. In the year 1995, the company set up joint venture in Russia. In the year 1997, they filled first ANDA with the United States Food and Drug Administration for Ranitidine. In the year 1999, the company acquired American Remedies Ltd, a pharmaceutical company based in India. In the year 2000, Cheminor Drugs Ltd, a group company merged with the company and thus the company became India's third largest pharma company. In the year 2001, the company launched Fluoxetine capsules. They became the first Indian company to win 180-day exclusivity for a generic drug in the US. Also, they launched their first generic product, Ranitidine, in the US market. In the year 2002, the company made their first overseas acquisition of BMS Laboratories Limited and Meridian Healthcare in UK. In the year 2003, they launched Ibuprofen, first generic product to be marketed under the 'Dr. Reddy's' label in the US. In the year 2005, they acquired Roche's API Business at its manufacturing site in Mexico. In the year 2006, the company acquired Betapharm the fourth largest generics company in Germany for a total enterprise value of Rs 480 million. In the year 2007, the company launched Reditux - the world's first biosimilar MAb - for the treatment of Non Hodgkins Lymphoma. Also, they became India's leading and most profitable pharmaceutical company. During the year 2008-09, the company acquired DowPharma's small molecules business in UK under Chirotech Technology Ltd, BASF Corporation's manufacturing facility at Shreveport in Louisiana, USA under Dr. Reddy's Laboratories Louisiana LLC and Jet Generici SRL, a company engaged in the sale of generic finished dosages in Italy. In addition, Perlecan Pharma Pvt Ltd, Macred India Pvt Ltd and Dr. Reddy's Laboratories ILAC Ticaret also became subsidiary of the company. During the year 2009-10, Dr. Reddy's Pharma SEZ Ltd was incorporated as a wholly-owned subsidiary of the company for the purpose of formulation manufacturing at Special Economic Zone and Perlecan Pharma Pvt Ltd was amalgamated with the company. Further, the company acquired the balance stake of 30% in Dr. Reddy's (Australia) Pty Ltd. The company filed 12 Abbreviated New Drug Applications (ANDAs) in US including six Para IV filing during the year. During the year 2010-11, the company acquired GlaxoSmithKline's (GSK) oral penicillin manufacturing facility located in Tennessee, USA. This allows the company to enter theUS penicillin-containing antibacterial market segment through brands such as Augmentin and Amoxil, and serve the needs of customers through manufacturing and other capabilities that did not previously exist within the company. Also, they increased the stake in the South African joint venture company to 100% after acquiring the 40% stake of the partner. During the year, the company launched Cresp in India, the first biosimilar darbepoetin alfa in the world. In March 2011, they launched Peg-grafeelTM in India in the form of an affordable pegfilgrastim, which is used to stimulate the bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy. Peg-grafeelTM During the year, Idea2Enterprises (India) Pvt Ltd, Dr. Reddy's Laboratories Romania SRL, I-Ven Pharma Capital Ltd, Dr. Reddy's Laboratories Tennessee LLC and Dr. Reddy's Venezuela C.A. became wholly-owned subsidiaries of the company. Further, Dr. Reddy's Laboratories (Proprietary) Ltd also became wholly-owned subsidiary by virtue of purchase of its balance 40% stake by the company. Also, Macred India Pvt Ltd ceased to be a subsidiary of the company.On 27 July 2012, Dr. Reddy's Laboratories announced that the United States Food and Drug Administration (USFDA) had lifted import alert on its chemical manufacturing facility at Cuernavaca, Mexico after inspection of the unit in March 2012. Earlier, Dr. Reddy's Mexico facility was inspected by USFDA in November 2010 and based on observations by the USFDA, a warning letter was issued to the company on 14 June 2011.On 8 October 2012, the Custom Pharmaceutical Services (CPS) business of Dr. Reddy's Laboratories Ltd. announced expansion in the areas of activated mPEG manufacturing and in the development and manufacture of NCE (New Chemical Entities) APIs for use in pre-clinical through to commercial development at its manufacturing facility in Mirfield, UK.On 14 December 2012, Dr. Reddy's Laboratories announced that it had launched the recommended public offer to acquire all the issued and outstanding shares of OctoPlus N.V., a service based specialty pharmaceutical company, at an offer price of EUR 0.52 (cum dividend) per share. Shareholders (including certain members of the Boards) holding in aggregate 63.5% of the issued and outstanding ordinary shares of OctoPlus entered into irrevocable undertakings to tender their shares under the offer. On 28 February 2013, Dr. Reddy's Laboratories announced that it had raised its stake in OctoPlus N.V, to 98.6% following a public offer for all the issued and outstanding ordinary shares in the capital of OctoPlus. OctoPlus is a leading European provider of advanced drug formulation and clinical scale manufacturing services to the pharmaceutical and biotechnology industries, with a focus on difficult-to formulate active pharmaceutical ingredients.On 19 December 2014, Dr. Reddy's Laboratories announced that it had completed the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc. following issuance of the proposed consent order from the US Federal Trade Commission (FTC) on 26 November 2014. The company had earlier entered into an asset purchase agreement with Novartis Consumer Health Inc. to acquire the title and rights of Habitrol brand and to market the product in the US market.On 22 March 2015, Dr. Reddy's Laboratories (NYSE: RDY) announced that it had settled its claims against Nordion Inc. (formerly MDS Inc.), headquartered in Ottawa, Canada, in a case pending in the United States District Court for the District of New Jersey, for a cash payment of USD 22.5 Million by Nordion to Dr. Reddy's. The case was brought by Dr. Reddy's in April 2009 seeking damages sustained by the company caused by a claimed breach by Nordion of its Laboratory Services Agreement with Dr. Reddy's. Nordion, as a contract research organization, provided laboratory services to Dr. Reddy's, including bio-equivalency studies, to support Dr. Reddy's regulatory applications for approval of generic drugs, including Abbreviated New Drug Applications (ANDAs) filed with the United States Food and Drug Administration (the USFDA) for approval to market generic drugs in the United States. The case arose after the USFDA cited MDS with violations of good laboratory practices which caused the USFDA not to accept, without further substantiation, MDS's laboratory reports performed during the period 2000-2004. On 23 March 2015, Dr Reddy's Laboratories announced that it has entered into an agreement with Hetero, under which Dr. Reddy's has been licensed to distribute and market Sofosbuvir 400 mg tablets , indicated in the treatment of Chronic Hepatitis C, under the brand name Resof, in India. On 1 April 2015, Dr. Reddy's Laboratories announced that it has entered into a definitive agreement to acquire a select portfolio of the established products business of UCB, a global biopharmaceutical company, in the territories of India, Nepal, Sri Lanka and Maldives. The revenue of the acquired business stood at approximately Rs 150 crore for calendar year 2014.On 29 May 2015, Dr Reddy's Laboratories Limited and AstraZeneca Pharma India Limited entered into a distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 DiabetesOn 6 August 2015, Dr. Reddy's Laboratories Ltd. announced that it has entered into a strategic collaboration with Amgen, one of the world's leading independent biotechnology companies, to market and distribute three Amgen medicines in India in the areas of oncology and cardiology. On 16 September 2016, Dr. Reddy's announced that it had expanded its strategic collaboration with Amgen to market and distribute three of Amgen's medicines in India in the therapy areas of oncology and osteoporosis. On 9 September 2015, PanTheryx Inc., a global medical nutrition company based in Boulder, Colorado, and Dr. Reddy's Laboratories Ltd. announced a multi-country supply and licensing agreement whereby Dr. Reddy's Lab got the exclusive right to market and distribute PanTheryx's breakthrough nutritional intervention, DiaResQ, for infectious diarrhea in India and Nepal and in process for Russia, Myanmar, Vietnam, Ukraine, Sri Lanka, Kazakhstan, Belarus, Jamaica, and select LATAM markets. Dr. Reddy's will market the product in India and Nepal under the Reliqua brand. On 14 September 2015, Dr. Reddy's Laboratories announced the signing of a commercialization deal with Hatchtech, an Australian pharmaceutical company developing an innovative prescription head lice product, Xeglyze Lotion. The exclusive rights for this product are applicable for the territories of the United States, Canada, India, Russia and the CIS, Australia, New Zealand and Venezuela. On 4 November 2015, Dr. Reddy's Laboratories entered into a strategic alliance with Biocodex, a multinational pharmaceutical company, to market and distribute Biocodex products in the Romanian market. On 5 November 2015, the US Food and Drug Administration (USFDA) issued a warning letter to Dr. Reddy's Laboratories relating to its API manufacturing facilities at Srikakulam, Andhra Pradesh and Miryalaguda, Telangana, as well as Oncology Formulation manufacturing facility at Duvvada, Visakhapatnam, Andhra Pradesh. This action follows the earlier inspections of these sites by the agency in November 2014, January 2015 and February 2015 respectively. On 18 November 2015, Dr. Reddy's Laboratories announced that it had completed the purchase of worldwide exclusive intellectual property rights for Fondaparinux sodium, its generic anti-coagulant drug from its Australian partner, Alchemia Limited. Earlier, the company had signed a term sheet for this transaction in September 2015. Fondaparinux is a generic version of the anticoagulant drug Arixtra. On 11 March 2016, Dr. Reddy's Laboratories Ltd. and TR-Pharm announced a strategic collaboration agreement for the manufacture and commercialization of a portfolio of Dr. Reddy's Laboratories' biosimilar drugs in Turkey. On 28 March 2016, Dr. Reddy's Laboratories and XenoPort, Inc. announced that they have entered into a license agreement pursuant to which Dr. Reddy's Laboratories will be granted exclusive US rights for the development and commercialization of XenoPort's clinical stage oral new chemical entity, XP23829. Dr. Reddy's Laboratories plans to develop XP23829 as a potential treatment for moderate-to-severe chronic plaque psoriasis and may potentially develop XP23829 for relapsing forms of multiple sclerosis (MS). On 31 March 2016, Dr. Reddy's Laboratories announced that it has entered into a licensing agreement with Eisai Co., Ltd, Japan by which Dr. Reddy's will be granted exclusive worldwide development and commercialization rights (excluding Japan and Asia) for Eisai's investigational anticancer agent E7777. Eisai will be responsible for the development and marketing of E7777 in Japan and Asia, while Dr. Reddy's holds the option for rights to develop and market the agent in India. On 25 May 2016, Dr. Reddy's Laboratories announced the acquisition of an eminent portfolio of over-the-counter (OTC) brands in the US in the cough-and-cold, pain, and dermatology categories from Ducere Pharma. On 3 August 2016, Dr. Reddy's Laboratories announced that it successfully completed the previously announced acquisition of a portfolio of complex generic products in the US from Teva Pharmaceutical Industries Ltd. and an affiliate of Allergan plc. On 11 June 2016, Dr. Reddy's Laboratories entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. and an affiliate of Allergan plc to acquire a portfolio of eight Abbreviated New Drug Applications (ANDAs) in the US for $350 million in cash. On 7 October 2016, Dr. Reddy's Laboratories announced its entry into Colombia with its portfolio of high quality and affordable medicines for Cancer patients. On 26 October 2016, Dr. Reddy's Laboratories announced that it had entered into a strategic collaboration with Gland Pharma, a globally recognized developer and manufacturer of sterile dosage forms, to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs) in the United States. On 8 February 2017, Dr. Reddy's Laboratories Ltd announced the expansion of its commercial operations in Europe with the introduction of its portfolio of generics in France. On 3 March 2017, Dr. Reddy's Laboratories announced that it had completed the acquisition of 100% stake in Imperial Credit Private Limited, a Non-Banking Finance Company (NBFC), based out of Kolkata, for a consideration of Rs 2.05 crore. The company proposes to undertake the group's captive financial activities through this entity. On 27 March 2017, Dr. Reddy's Laboratories and Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that they have entered into an exclusive distribution agreement. Under the agreement, Dr. Reddy's will market and distribute DuraGen Plus and Suturable DuraGen Dural Regeneration Matrices for use in patients in India. The DuraGen product line offers Duraplasty Solutions meant for the repair of the dura mater. Dura mater is a thick membrane that surrounds the brain and spinal cord, and contains the cerebrospinal fluid (CSF). DuraGen Plus Dural Regeneration Matrix is indicated as a dural substitute for the repair of dura mater. On 27 July 2017, Dr Reddy's Laboratories Ltd. and CHD Bioscience Inc., a privately-held biopharmaceutical company, announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy's phase III clinical trial candidate, DFA-02. It is intended to be used for the prevention of surgical site infections, following non-emergency, elective colorectal surgery. Under the terms of the agreement, Dr. Reddy's would receive equity in CHD valued at $30 million upon an IPO of CHD or a minimum of $30 million in cash within 18 months of execution of the agreement. Dr. Reddy's will also receive additional milestone payments of $40 million upon USFDA approval. In addition, CHD will pay Dr. Reddy's double-digit royalties on sales and commercial milestones. On 22 August 2017, Dr. Reddy's Laboratories Ltd. through its wholly owned subsidiary Promius Pharma, LLC, announced that it has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology Inc. The drug is intended to be used for treatment of moderate to severe plaque psoriasis. Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United States. Promius Pharma is eligible to receive certain pre- and post- commercialization milestone payments of up to USD $32.5 million, followed by fixed royalty payments on net sales. On 19 December 2017, Dr. Reddy's Laboratories Ltd. announced that its US subsidiary had reached a settlement with the US Government in a case involving packaging for five blister-packed prescription products. In a joint filing by the parties, Dr. Reddy's and the US Department of Justice agreed to the settlement of the action without any adjudication of any issue of fact or law. In FY2018, the company filed 19 new Abbreviated New Drug Applications (ANDAs) and one New Drug Application (NDA) with the USFDA. As of 31 March 2018, the company had 110 generic filings pending approval from the USFDA, comprising 107 ANDAs and three NDAs filed under the 505(b)(2) route of the US Federal Food, Drug and Cosmetic Act. Of the 107 ANDAs, 63 are Para IV applications. The company had 51 subsidiaries and two joint venture companies as on 31 March 2018. During FY2018, Dr. Reddy's Laboratories Chile SpA. (in Chile), Dr. Reddy's (WUXI) Pharmaceutical Co. Limited (in China), Dr. Reddy's Laboratories Malaysia Sdn. Bhd. (in Malaysia) and Dr. Reddy's Laboratories Taiwan Limited (in Taiwan) have become subsidiary companies. DRSS Solar Power Private Limited was closed and ceased to be a joint venture company. In FY2019, the company filed 20 new Abbreviated New Drug Applications (ANDAs) with the USFDA. As on 31 March 2019, the company had 110 generic filings pending approval from the USFDA - comprising 107 ANDAs and three New Drug Applications (NDAs). The company had 52 subsidiaries and two joint venture companies as on 31 March 2019. During FY2019, Dr. Reddy's Laboratories (Thailand) Limited and Dr. Reddy's Laboratories Philippines Inc. have become subsidiary companies. Pursuant to sale of all the issued and outstanding membership interests in the antibiotic manufacturing facility at Tennessee, USA, Dr. Reddy's Laboratories Tennessee, LLC ceased to be a subsidiary. During FY2019, the company launched 15 new brands in India. The company spent towards R&D expenses during FY2019 for the amount of Rs 15,607 million, or 10.1% of revenue, versus 12.9% in FY2018. The company had 50 subsidiaries and two joint venture companies as on 31 March 2020. During FY2020, Aurigene Pharmaceutical Services Limited was incorporated as a step-down subsidiary company. Dr. Reddy's Singapore Pte. Limited and Reddy Antilles N.V. were closed and ceased to be wholly-owned subsidiaries. Dr. Reddy's Laboratories International SA ceased to be a step-down subsidiary of the company consequent to its merger with Dr. Reddy's Laboratories SA. During FY2020, the company launched 21 new brands in India. The company also entered the nutrition segment with the launch of our diabetes nutrition drink Celevida'. The company spent towards R&D expenses during FY2020 amounting to Rs 15,410 million, or 8.8% of revenue, versus 10.1% in FY2019. On 10 June 2020, the company completed the acquisition of select divisions of Wockhardt Limited's branded generics business in India and the territories of Nepal, Sri Lanka, Bhutan and Maldives. The business comprises a portfolio of 62 brands in multiple therapy areas, such as respiratory, neurology, venous malformations, dennatology, gastroenterology, pain, and vaccines. This entire portfolio has been transferred to the Company, along with related sales and marketing teams, the manufacturing plant located in Baddi, Himachal Pradesh, and employees. During the quarter ended 30 September 2020, the company completed the purchase price allocation. The fair value of consideration transferred is Rs 16,115 million. The company recognised Rs 373 million, Rs 14,888 million and Rs 530 million towards property, plant and equipment, intangible assets, and goodwill, respectively. The acquisition pertains to Company's Global Generics segment. On 22 October 2020, the Company experienced a cybersecurity incident related to ransomware. The Company could contain the incident in a timely fashion and has also ensured that all traces of the infection are completely cleaned from the network. All affected systems were restored and brought back to normalcy in the order of priority. Based on the forensic investigation, no evidence was found of any data breaches leading to personally identifiable information. Since then, the Company has also been focused on implementing significant improvements to its cyber and data security systems to safeguard from such risks in the future. The Company continues to consider the impact of COVID-19 pandemic in assessing the recoverability of receivables, goodwill, intangible assets, and certain investments. During December 2020, the company entered into a definitive agreement with Glenmark Phannaceuticals Ltd. to acquire, certain brands in various Emerging Market countries for a total consideration of Rs 1,516 million. The said transaction was accounted for as an acquisition of product related intangibles. In FY 2020, Company filed 8 new Abbreviated New Drug Applications (ANDAs) with the USFDA. As on 31 March 2020, there were 99 generic filings pending approval from the USFDA, comprising 97 ANDAs and 2 New Drug Applications (NDAs). During the year, the Company filed 20 abbreviated new drug applications (ANDAs) and 1 new drug application (NDA) in the USA. As of March 31, 2021, there were 95 generic filings awaiting approval with the US Food and Drug Administration (USFDA), comprising 92 ANDAs and 3 NDAs. The company had 52 subsidiaries and 1 joint venture company as on March 31, 2021. During FY 2021, Dr. Reddy's (Beijing) Pharmaceutical Company Limited in China and Dr. Reddy's Formulations Limited in India were incorporated as a step-down subsidiary company and a wholly-owned subsidiary, respectively. Pursuant to sale of the membership interests in DRANU, LLC, it ceased to be a joint venture during the year. Further, the company sold its Contract Development and Manufacturing Organization (CDMO) division of Custom Pharmaceutical Services (CPS) business to Aurigene Pharmaceutical Services Limited (APSL), a wholly-owned subsidiary, on slump sale basis, for a consideration of Rs. 5,434.5 million. During year 2022, Company filed 7 Abbreviated New Drug Applications (ANDAs) in the USA. As of March 31, 2022, there were 90 generic filings awaiting approval with the US Food and Drug Administration (USFDA), comprising 87 ANDAs and 3 NDAs. The Hon'ble National Company Law Tribunal (NCLT), Hyderabad Bench, vide order dated April 5, 2022, has approved the Scheme of Amalgamation and Arrangement for the merger of Dr. Reddy's Holdings Limited (the DRHL/ Amalgamating Company) with the Company, filed by both companies with the Registrar of Companies, Hyderabad, on April 8, 2022. Therefore, the merger became effective on April 8, 2022 with Appointed date of the Scheme, April 1, 2019. The Company has 42 overseas subsidiary companies (including step-down subsidiaries), 9 subsidiary companies in India and 1 joint venture Company as on March 31, 2022. Dr. Reddy's (WUXI) Pharmaceutical Co. Limited in China ceased to be a step-down subsidiary of the Company with effect from December 13, 2021, consequent to its liquidation. Aurigene Discovery Technologies Inc. in USA, ceased to be a step-down subsidiary of the Company with effect from March 23, 2022, consequent to its liquidation. Further, the Company acquired Nimbus Health GmbH (Nimbus) as a step-down subsidiary, on February 24, 2022. During the year 2022-23, Dr. Reddy's Holdings Limited (the DRHL/ Amalgamating Company) got merged with Dr Reddy's Laboratories Ltd. (the Amalgamated Company) through the Scheme of Amalgamation and hence, the merger became effective on April 8, 2022. Consequent to the merger with Dr. Reddy's Laboratories LLC, Russia, DRS LLC in Russia ceased to be a step down subsidiary of the Company with effect from July 1, 2022. Dr. Reddy's Laboratories B.V. in Netherlands, has ceased to be a step-down subsidiary of the Company with effect from January 25, 2023. During the year 2023, the Company launched the generic version of Lenalidomide Capsules, a cancer drug used to treat myeloma in the United States; launched Sorafenib tablets, a drug used to treat a type of liver cancer called hepatocellular carcinoma; launched Timolol gel, an ophthalmic gel forming solution used to treat glaucoma. In 2024, Company diversified the business to patients women's healthcare in the US Consumer Healthcare and its first ever biosimilar in the UK, and vaccines in India. It took step in the area of digital therapeutics, with the launch of the drug-free migraine management device Nerivior, and a digital integrated care plan to manage Irritable Bowel Syndrome (IBS). The Company formed a joint venture with Nestlé India to introduce health science nutraceutical products to consumers across India and other agreed territories. It entered the UK consumer health market with the launch of the OTC allergy medication Histallay.

Parent Organisation

Dr. Reddy's

NSE Symbol

DRREDDY

Founded

1984

View more stocks

IOL CHEM AND PHARMA LTD

₹85.53

8.04%

CAPLIN POINT LAB LTD.

₹2272.0

6.81%

ACCENT MICROCELL LIMITED

₹238.9

5.05%

GLAND PHARMA LIMITED

₹1567.0

4.58%

GLAXOSMITHKLINE PHARMA LT

₹2914.1

4.57%

MARKSANS PHARMA LIMITED

₹245.71

3.77%

FDC LIMITED

₹470.05

3.06%

MEGASOFT LTD

₹78.0

3.03%

SEQUENT SCIENTIFIC LTD.

₹173.84

2.62%

INFINIUM PHARMACHEM LTD

₹309.0

2.62%

Popular stocks

Rail Vikas Nigam
Suzlon Energy
NHPC
Yes Bank
TATA Motors
BHEL
HDFC Bank
State Bank of India
TATA Power
TATA Steel
NBCC India
Infosys India
Adani Power
IFCI
Coal India
OLA Electric

What’s trending

Top gainers Top losers 52-week high 52-week low All stocks

All stocks

VGINFOTECH

VIRTUAL GALAXY INFOTECH L

189

+47 +33.1%

BANCOINDIA

BANCO PRODUCTS (I) LTD

494.5

+82.4 +20%

KAYA

KAYA LIMITED

343.2

+57.2 +20%

KAYA

KAYA LIMITED

342.35

+57.05 +20%

View all

Top gainers

BAJAJ-AUTO

BAJAJ AUTO LIMITED

8851

+368.50 +4.34%

SHRIRAMFIN

SHRIRAM FINANCE LIMITED

677.8

+12.30 +1.85%

POWERGRID

POWER GRID CORP. LTD.

304.05

+3.85 +1.28%

HEROMOTOCO

HERO MOTOCORP LIMITED

4387.7

+42.40 +0.98%

View all

Top losers

ETERNAL

ETERNAL LIMITED

238.03

-7.73 -3.15%

GRASIM

GRASIM INDUSTRIES LTD

2727

-77.20 -2.75%

INFY

INFOSYS LIMITED

1559.8

-30.10 -1.89%

TATACONSUM

TATA CONSUMER PRODUCT LTD

1149.3

-18.70 -1.60%

View all

Frequently asked questions

What is share price of DR. REDDY S LABORATORIES?
<p> As of May 21 2025 01:03 PM, at May 21 2025 01:03 PM, the DR. REDDY S LABORATORIES share price stands at Rs.1226.6.</p>
What is the market cap of DR. REDDY S LABORATORIES?
<p>As of May 21 2025 01:03 PM, the market cap of DR. REDDY S LABORATORIES stands at Rs.20461.93 Cr. <br /> </p>
What is the PE and PB ratio of DR. REDDY S LABORATORIES?
<p> The PE and PB ratios of DR. REDDY S LABORATORIES is 19.11 ratio and 345.81 ratio as of May 21 2025 01:03 PM.</p>
What is the 52 week high and low of DR. REDDY S LABORATORIES?
<p>The 52 week high and low of DR. REDDY S LABORATORIES is Rs.1421.49 and Rs.1020.0 as of May 21 2025 01:03 PM.<br /> </p>
How can I buy DR. REDDY S LABORATORIES share?
<p>You can easily buy&nbsp;DR. REDDY S LABORATORIES shares on&nbsp;the <b>Bajaj Broking</b> platform by opening a Demat account&nbsp;and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.<br> </p>
Show More Text Show Less Text

Related articles

Article 1

How to Buy Shares

Jan 30, 2025

Read More

share-market-timings-in-india 2

Share Market Timings in India

May 15, 2023

Read More

what-is-trading 3

What is Trading

Mar 25, 2025

Read More

what-is-demat-account 4

What is Demat Account: Meaning, Types & Benefits

May 25, 2021

Read More


Related videos

Features and benefits of Demat Account
 
 

Features and benefits of Demat Account

How to open a Demat and Trading account with us
 
 

How to open a Demat and Trading account with us

Stock market basics for beginners
 
 

Stock market basics for beginners

Features and Benefits of a Trading account
 
 

Features and Benefits of a Trading account

Different types of Demat accounts
 
 

Different types of Demat accounts


Related tags

Top gainers
Top losers
52 week high
52 week low
All stocks

You are here

  1. Home
  2. Investments
  3. Dr. ReddyS Laboratories Share Price

Related links

  • Investments
  • Brokerage calculator
  • Demat account
  • Trading account

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."
 

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines. Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.


Powered by Bajaj Financial Securities Limited (Bajaj Broking)

Go To Top

Application Forms

  • Personal Loan
  • Business Loan
  • Home Loan
  • Gold Loan
  • Insta EMI Card
  • Wallet Care
  • Health Insurance
  • Loan for Doctors
  • Fixed Deposit
  • Loan Against Property
  • Loan for Chartered Accountants
  • Open Demat Account
  • Two-wheeler Loan
  • New Car Finance
  • Used Car Loan
  • Loan Against Car
  • Car Loan Balance Transfer and Top-up
  • Mutual Fund
  • Secured Business Loan
  • Loan for Lawyer

Products Portfolio

Loans

  • Personal Loan
  • Insta Personal Loan
  • Business Loan
  • Home Loan
  • Gold Loan
  • MSME Loan
  • Mortgage Loan
  • Loan Against Property
  • Two & Three Wheeler Loan
  • Education Loan on Property
  • Personal Loan for Self-employed Individuals
  • Two-wheeler Loan
  • New Car Finance
  • Used Car Loan
  • Loan Against Car
  • Car Loan Balance Transfer and Top-up
  • Used Cars and Loan

Insurance

  • Health Insurance
  • Car Insurance
  • Pocket Insurance
  • Investment Plans
  • Appliances Extended Warranty
  • Pocket Subscription

Finance for Professionals

  • Loan for Doctors
  • Loan for Chartered Accountants

Investments

  • Fixed Deposit
  • Open Demat Account
  • Mutual Funds
  • NFO (New Fund Offer)
  • ELSS Mutual Funds
  • Equity Mutual Funds
  • Hybrid Mutual Funds
  • Debt Mutual Funds
  • Multi Cap Mutual Funds
  • Large Cap Mutual Funds
  • Mid Cap Mutual Funds
  • Small Cap Mutual Funds
  • Liquid Mutual Funds
  • Aggressive Hybrid Mutual Funds

Pocket Subscription

  • Mobile Protection Plan
  • Wallet Care
  • Fonesafe Lite
  • Neuro Care Plan
  • Health Prime Max
  • Cpp Road Assist
  • Healthy Body Package

Bajaj Mall

  • Smartphones
  • Mattress
  • Smartwatches
  • Cycles
  • Music & Audio
  • Speakers
  • Water Purifiers
  • Laptops
  • Two-wheeler
  • Washing Machine
  • Televisions
  • Air Conditioner
  • Refrigerators
  • Furniture

Services

  • Sign-in to our Customer Portal (My Account)
  • Manage your Profile
  • Manage your Mandate
  • Manage your Loans
  • Manage your Flexi Loans
  • Manage your Insta EMI card
  • Manage your Fixed Deposit

Wallets & Cards

  • Wallet
  • Bajaj Finserv Insta EMI Card

Value Added Services

  • Credit Pass
  • Gold Rate

Payments

  • All Payments
  • Wallet
  • UPI
  • Mobile recharge
  • Electricity Bill Payment
  • DTH Recharge
  • Loan Repayment
  • Gas Booking
  • Rewards
  • Bajaj Pay FASTAg
  • Bajaj Pay Wallet KYC Upgrade
  • Bajaj Pay FASTAg Registration
  • Bajaj Pay FASTag Replacement
  • Bajaj Pay FASTag Closure
Pre-approved Offers
Offers & Promotions
Article and Insights

Calculators

  • Personal Loan EMI Calculator
  • Home Loan EMI Calculator
  • Home Loan Eligibility Calculator
  • Business Loan EMI Calculator
  • Personal Loan Eligibility Calculator
  • Loan Against Property EMI Calculator
  • Education Loan on Property Calculator
  • FD Calculator
  • Gratuity Calculator
  • Income Tax Calculator
  • Top-up Loan Calculator
  • Part-prepayment Calculator
  • GST Calculator
  • Gold Loan Calculator
  • EMI Calculator
  • Used Car Loan EMI Calculator
  • Interest Calculator
  • SIP Calculator
  • Credit Score Simulator
  • Flexi Day Wise Interest Calculator
  • Flexi Transaction Calculator
  • Secured Business Loan EMI Calculator
  • Secured Business Loan Eligibility Calculator
  • Lumpsum Calculator
  • Step Up SIP Calculator
  • BMI Calculator
  • IDV Calculator
  • Commercial Loan EMI Calculator
  • Medical Equipment Finance EMI Calculator
  • Term Loan Calculator
  • Equipment Machinery Loan EMI Calculator
  • Doctor Loan EMI Calculator
  • Doctor Loan Eligibility Calculator
  • Chartered Accountant Loan EMI Calculator
  • Simple Interest Calculator
  • Compound Interest Calculator
  • Brokerage Calculator
  • Mutual Fund Calculator
  • Two wheeler Loan EMI Calculator
  • New Car Loan EMI Calculator

Legal

  • Moratorium Policy (Covid-19)
  • Moratorium Policy March 2020
  • Information Security Practices
  • Information Security Measures
  • Citizens Charter
  • Privacy Policy
  • Phishing
  • Disclaimer
  • Forms Centre
  • Fees & Charges
  • Fair Practices Code
  • Interest Rate Policy
  • Disclosures
  • Cautionary Notice
  • Whistle Blower Policy
  • Confidential Feedback
  • Resolution Plan 2.0
  • Terms & Conditions
  • Resolution Plan 2.0 FAQs
  • Ombudsman Scheme
  • SMA/NPA Account Classification
  • Terms of Use
  • Sachet
  • Handover of Property Documents
  • Notices
  • Policy on Fees & Charges
  • BFL - Floating Reference Rates

Reach Us

  • Contact us
  • Raise A Request
  • Frequently Asked Questions
  • Make Online Payment
  • Branch Locator
  • Our Partners
  • Galaxy - Partner portal
  • Bajaj Finserv for Business
  • Call Us

Corporate Office

6th Floor Bajaj Finserv Corporate Office, Off Pune-Ahmednagar Road, Viman Nagar, Pune - 411014

Bajaj Finance Limited Regd. Office

Akurdi, Pune - 411035
Ph No.: 020 7157-6403
Email ID: investor.service@bajajfinserv.in

Corporate Identity Number (CIN)

L65910MH1987PLC042961

IRDAI Corporate Agency (Composite) Regn No.

CA0101
(Valid till 31-Mar-2028)

URN - WEB/BFL/23-24/1/V1

Bajaj Finserv Limited Regd. Office

Bajaj Auto Limited Complex Mumbai - Pune Road,
Pune - 411035 MH (IN)
Ph No.: 020 7157-6064
Email ID: investors@bajajfinserv.in

Corporate Identity Number (CIN)

L65923PN2007PLC130075

Our Companies

  • Bajaj Finserv Ltd.
  • Bajaj Finance Ltd.
  • Bajaj Allianz General Insurance
  • Bajaj Allianz Life Insurance
  • Bajaj Markets
  • Bajaj Housing Finance Ltd.
  • Bajaj Broking
  • Bajaj Finserv Health Ltd.
  • Bajaj Finserv Asset Management Ltd.
Company Name
Download App

© Bajaj Finserv 2007-2025. All rights reserved.